Sucralfate Market to Grow at a CAGR of 4.8% during the Forecast Period

The Global Sucralfate Market is expected to grow at a CAGR of 4.8% over the forecast period. Sucralfate is a prescription medicine used to treat upper gastrointestinal tract ulcers and peptic ulcers, and also to prevent ulcer reoccurrences. Sucralfate is a sucrose octasulfate hydroxy aluminum salt, and it works as a local mucosal adherent. By sticking to the affected area, it forms a coating over ulcers that protects the area from acid and enzymes and thus, helps them to heal faster.

Sucralfate may also be used to treat ulcers in dogs, horses, and cats, as well as for treating upper gastrointestinal disorders in them that may be caused by the intake of certain medications such as non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids, toxic chemical intake, liver diseases, kidney failure, carcinoma, stress (trauma, shock, sepsis, and burns), and inflammatory bowel diseases. Sucralfate primarily works on the stomach lining and is not highly absorbed into the bloodstream. By adhering to the sites of ulcers, it protects them from acids, bile salts, and enzymes.

Increasing demand, growing urbanization and industrialization, and product creation & technological developments are the factors that are propelling the growth of the global sucralfate market. Factors such as increasing geriatric population across the globe and the rising occurrence of intestinal ulcers are also driving the growth of the global market.

On the other hand, side effects such as moderate itching or skin rash, nausea, vomiting, stomach upset, headache, etc., which can be caused by the intake of sucralfate, can restrain the growth of the global market. However, the growth of the sucralfate market is expected to be driven by increased research and development activities for the development of new medicine using sucralfate. For example, the use of sucralfate along with honey may help in the treatment of esophageal injury in infants and children, according to the American Broncho Esophagological Association study in April 2018.

In infants and children, esophageal injury has been often found to be associated with the ingestion of Button Batteries (BB), the small batteries that are typically used in toys. The usage of honey and sucralfate has been found to be effective in minimizing the discharge of button batteries and in providing symptomatic relief from esophageal injury.

However, the scarcity of drugs is expected to impede the growth of the demand for sucralfate. For example, according to the September 2018 Drug Shortages Canada study, APO-SUCRALFATE - TAB 1G (APOTEX INC) containing sucralfate was not available due to the disruption in the production of the drug. The medicine is used to treat peptic ulcer and gastroesophageal reflux disease (GERD).

In order to prevent any significant side effects of sucralfate, the key players in the industry and government authorities are focusing on updating the product details and building awareness. For instance, in August 2017, Teva Pharmaceutical Industries, Ltd. as well as Mylan, Inc. obtained the U.S. Food and Drug Administration’s approval for change in the labelling data. The warning and precautionary measures included the marking of risks such as pulmonary and cerebral emboli due to improper intravenous administration of Carafate (Sucralfate).

Global Sucralfate Market, By Type

In terms of type, the global sucralfate market is segmented into powder and suspension. The powder segment will dominate the market, as it ensures faster healing of ulcers. Powders are more stable than the liquid forms. Further, compared to the liquid dosage type, the risk of incompatibility is also smaller. The powdered drugs are also known for their faster onset of action than other solid dosage types.

Global Sucralfate Market, By End-User

In terms of end-user, the global sucralfate market is segmented into hospitals, laboratory, and others. The hospital segment is anticipated to dominate the market owing to the growing geriatric population. Further, rising incidence of intestinal ulcers is also expected to help the hospital segment maintain its growth momentum.

Global Sucralfate Market, By Distribution Channel

In terms of the distribution channel, the global market is segmented into online stores and offline stores. Among these, the online stores segment is likely to dominate the market, as more and more consumers are switching to the online platform. As nowadays everything is available on the mobile phone on a single click, the online platform enables people to evade long lines and crowds of offline stores.

Global Sucralfate Market, By Geographical Regions

At present, North America is holding a dominant position in the sucralfate market, and this dominance can be explained by the increasing number of clinical studies being carried out in the region. The North American market is followed by Western Europe, China, Japan, Southeast Asia, India, and Central & South America.

However, during the forecast period, the Asia Pacific region is expected to report a higher growth rate in the sucralfate market. The growth of this regional market will be mainly driven by the increasing incidence of peptic ulcer associated with H. pylori, as well as the rising occurrence of gastric cancer and gastric mucosa-associated lymphoid tissue (MALT) lymphoma. 

Key Market Developments:

  • In 2017, the U.S. FDA updated the name of 'Carafate suspension' to 'Carafate oral suspension' to evade major complications with mistaken intravenous administration of the medicine.
  • According to the report of American Broncho Esophagological Association in 2018, the use of sucralfate along with honey helps in treating esophageal injury in children and infants.

Some Key Findings of the Global Sucralfate Market Report Include:

  • A comprehensive analysis of the global market.
  • Year-on-year growth of the global sucralfate market in terms of value and volume.
  • Historic and future progress of the global market.
  • Region-wise and country-wise analysis of the global sucralfate market to get the share and growth details in these areas.
  • Several key factors that are affecting the consumption pattern of consumers across a number of regions and countries.
  • Strategic frameworks of the global sucralfate market to boost the growth journey.
  • Wide-ranging insights on the current R&D activities performed by each market service provider.
  • Some of the key players in the global market are SRL Pharma, Nitika Pharmaceuticals Specialties Pvt. Ltd., Lisapharma S.p.A, Aptalis Pharma US, Inc., Uniprix Group, Rx Outreach, Teva Pharmaceutical Industries Ltd., Abcam Plc, and Quimica Alkano.

Market Segmentation:

By Type

  • Powder
  • Suspension

By End Users

  • Hospitals
  • Laboratory
  • Others

By Distribution Channel

  • Offline stores
  • Online Stores

By Geographical Regions

  • North America
  • Europe
  • Asia Pacific
  • MEA
Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision


Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements